Trial Profile
A Phase IIa, Double-blind, Randomised, Parallel-group, Multi-centre Study to Evaluate the Analgesic Efficacy of 28 days' Oral Administration of AZD2423 Compared with Placebo in Patients with Painful Diabetic Polyneuropathy.
Status:
Suspended
Phase of Trial:
Phase II
Latest Information Update: 21 Apr 2011
Price :
$35
*
At a glance
- Drugs AZD 2423 (Primary)
- Indications Diabetic neuropathies; Neuropathic pain
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 30 Apr 2010 New trial record